| |
|
ABSTRACT |
SLIDES |
|
| 08:30 |
Registration |
|
|
|
| 09:00 |
Welcome |
|
|
Ann Henry, Leeds |
| 09:10 |
Molecular Imaging in Prostate Cancer – Current Status and Future Prospects |
|
 |
Andy Scarsbrook, Leeds |
| 09:40 |
Biofocussed prostate cancer RadioTherapy (BiRT) |
|
 |
Annette Haworth, Australia |
| 10:20 |
Coffee; Exhibition/Poster viewing |
| 10:50 |
Optimal fractionation in HDR brachytherapy |
|
 |
Gerard Morton, Canada |
| 11:30 |
Minimising and managing morbidity in LDR brachytherapy |
|
 |
Mira Keyes, Canada |
| 12:10 |
Patient contamination in prostate LDR brachytherapy |
|
 |
Sarah Aldridge, London |
| 12:30 |
Lunch; Exhibition/Poster viewing |
| 13:30 |
Proffered papers – Clinical |
|
|
Chairs: Annette Haworth
and Gerard Morton |
| 14:15 |
Breakout sessions |
| |
Physics: Verification/Uncertainties Theme |
|
|
Chair: Peter Bownes, Leeds |
| |
Differences in dosimetry, planning and equieffective doses for prostate brachytherapy |
|
 |
Annette Haworth, Australia |
| |
In-vivo dosimetry in clinical practice |
|
 |
Joshua Mason, Victoria Coleman, Leeds |
| |
Proffered papers – Physics |
|
|
|
| |
Clinical: Toxicity Theme |
|
|
Chair: Sree Rodda, Leeds |
| |
Screening for and managing radiation bowel toxicity |
|
 |
John Staffurth, Cardiff |
| |
Medical management of sexual dysfunction |
|
|
Ian Eardley, Leeds |
| |
Management of psycho-sexual dysfunction after prostate cancer treatment |
|
 |
Lorraine Grover, London |
| |
Abstracts |
| |
LDR versus HDR brachytherapy boost in prostate cancer patients – a retrospective analysis |
 |
|
Sree Rodda |
| |
Pre-operative membranous urethral length predicts early return of continence in patients undergoing salvage robotic assisted radical prostatectomy |
 |
|
Sadat Yazdouni |
| |
Outcomes from intermediate risk, Gleason 7, localised prostate cancer treated with low-dose rate brachytherapy |
 |
|
Robert Maher |
| |
Salvage High Dose Brachytherapy at the Bristol Cancer Institute – Experience and Challenges |
 |
|
Susan Masson |
| |
The Design and Development of Patient-based Anthropomorphic Prostate Training Devices for Novice Oncologists for Trans rectal Ultrasound (TRUS) Guided Prostate Imaging |
 |
|
Andrea J Doyle |
| |
Robotic Prostate Biopsy and LDR/HDR Brachytherapy under MRI Guidance: Update from the EU-funded CoBra Project |
 |
|
Sarah Wilby |
| |
Acute urinary toxicity following HDR brachytherapy for prostate cancer: comparing outcomes with CT only treatment planning versus CT and MRI |
 |
|
Emily Farrow |
| |
Patient satisfaction and patient reported outcomes (PROMS) following HDR brachytherapy for prostate cancer at the Sussex Cancer Centre |
 |
|
Ashok Nikapota |
| 15:45 |
Coffee; Exhibition/Poster viewing |
| 16:15 |
Debate:
Which is best: LDR or HDR boosting when combining with EBRT? |
|
 |
Chair: David Bottomley, Leeds
Gerard Morton, Canada
and Mira Keyes, Canada |
| 17:00 |
Closing remarks and presentation of prizes |
|
|
Ann Henry and Peter Bownes,
Leeds |
| Evening |
Conference Dinner |
|
|
|